HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/19122144

Proc. Natl. Acad. Sci. U.S.A. 2009 Jan 13 106 2 474-9

Download in:

View as

Triples

General Info

PMID
19122144